Capital World Investors 13D and 13G filings for Vertex Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-13 4:53 pm Purchase | 2024-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | Capital World Investors | 28,739,975 11.200% | 2,837,037 (+10.95%) | Filing |
| 2024-04-10 12:14 pm Purchase | 2024-04-10 | 13G | Vertex Pharmaceuticals Incorporated VRTX | Capital World Investors | 25,902,938 10.000% | 3,822,731 (+17.31%) | Filing |
| 2024-02-09 6:19 pm Purchase | 2024-02-07 | 13G | Vertex Pharmaceuticals Incorporated VRTX | Capital World Investors | 22,080,207 8.600% | 9,140,888 (+70.64%) | Filing |
| 2023-02-13 2:49 pm Purchase | 2023-02-14 | 13G | Vertex Pharmaceuticals Incorporated VRTX | Capital World Investors | 12,939,319 5.000% | 5,564,740 (+75.46%) | Filing |